No Matches Found
No Matches Found
No Matches Found
TCM Stock Hits New 52-Week High of Rs.81, Marking Significant Milestone
TCM, a key player in the Commodity Chemicals sector, reached a new 52-week high of Rs.81 today, reflecting a notable phase of momentum and market activity. This milestone underscores the stock’s recent performance strength amid a broadly positive market environment.
TCM Ltd Surges to New 52-Week High Amid Unprecedented Buying Interest
TCM Ltd has witnessed extraordinary buying momentum, hitting a fresh 52-week high of Rs. 74.33 with only buy orders in the queue, signalling a potential multi-day upper circuit scenario. The stock’s performance starkly contrasts with the broader market, reflecting robust investor enthusiasm in the commodity chemicals sector.
TCM Hits New 52-Week High of Rs.74.33, Marking Significant Milestone
TCM, a key player in the Commodity Chemicals sector, reached a fresh 52-week high of Rs.74.33 today, underscoring a notable rally in its stock price amid broader market fluctuations.
TCM Stock Hits New 52-Week High of Rs.67.58 Marking Significant Milestone
TCM, a key player in the Commodity Chemicals sector, reached a new 52-week high today, touching Rs.67.58. This milestone reflects notable momentum in the stock’s price movement amid a broadly positive market environment.
TCM Ltd Hits Upper Circuit Amidst Unprecedented Buying Interest
TCM Ltd, a key player in the Commodity Chemicals sector, witnessed extraordinary buying momentum today, hitting its upper circuit with only buy orders in the queue. This surge reflects a remarkable market enthusiasm, with the stock touching a fresh 52-week high of Rs. 67.58, significantly outperforming the broader Sensex and its sector peers.
Why is TCM falling/rising?
As of 17-Nov, TCM Ltd's stock price is Rs. 65.90, up 4.72%, and has reached a 52-week high of Rs. 67.5. Despite a significant drop in delivery volume, TCM has outperformed its sector and the Sensex, indicating strong investor interest and a bullish trend.
TCM Achieves New 52-Week High of Rs. 67.5, Reflecting Strong Performance
TCM, a microcap in the commodity chemicals sector, achieved a new 52-week high of Rs. 67.5 on November 17, 2025, outperforming its sector. The stock has shown strong momentum, gaining 4.99% over two days, and is trading above key moving averages, reflecting a solid market position.
TCM Achieves New 52-Week High of Rs. 67.5, Surges 4.99%
TCM, a microcap in the commodity chemicals sector, achieved a new 52-week high of Rs. 67.5 on November 17, 2025, reflecting strong performance. The stock has consistently gained over the past days and is trading above key moving averages, while the broader market shows positive trends.
How has been the historical performance of TCM?
TCM's historical performance shows significant fluctuations, with net sales peaking at 32.23 Cr in March 2024 before declining to 26.01 Cr in March 2025. However, the company reported a recovery in profitability, achieving a profit after tax of 1.40 Cr in March 2025, up from a loss of 2.29 Cr the previous year.
TCM Ltd Surges 5% Today, Achieves 44.46% Monthly Gain, Trading Above Key Moving Averages
TCM Ltd, a microcap in the commodity chemicals sector, is experiencing notable buying activity, with a 10.2% total return over two days. The stock has shown significant volatility, rebounding from an initial loss and achieving a 44.46% increase over the past month, outperforming the Sensex.
Are TCM latest results good or bad?
TCM's latest Q2 FY26 results are poor, showing a net loss of ₹2.24 crores and a 58.04% revenue decline, indicating significant operational challenges and negative cash flow. The company's transition to a diversified trading model has not achieved sustainable profitability, raising concerns about its future viability.
TCM Ltd Surges 4.98% Today, Rebounding from Intraday Low to High of Rs 60.24
TCM Ltd, a microcap in the commodity chemicals sector, is experiencing notable buying activity, rebounding after three days of decline. The stock has shown impressive monthly growth, significantly outperforming the Sensex, despite recent volatility. Today's trading reflects a strong relative performance compared to broader market trends.
TCM Ltd Q2 FY26: Losses Deepen Amid Revenue Collapse, Operational Crisis Intensifies
TCM Limited, a micro-cap commodity chemicals company with a market capitalisation of ₹45.05 crores, reported a devastating Q2 FY26 performance that underscored the deepening operational crisis facing the Cochin-based enterprise. The company posted a consolidated net loss of ₹2.24 crores for the quarter ended June 2025, representing a sharp deterioration from the ₹4.03 crores profit recorded in Q1 FY26 and a 128.57% year-on-year decline from the ₹0.98 crores loss in Q2 FY25. Despite the troubling financial results, shares surged 4.98% to ₹60.24 following the announcement, reflecting speculative trading rather than fundamental strength.
TCM Ltd Faces Significant Selling Pressure, Declines 4.98% Today Amid Four-Day Loss Streak
TCM Ltd is experiencing significant selling pressure, marking its fourth consecutive day of losses and a notable decline in stock price. Despite recent gains over the past month and three months, the company's long-term performance shows challenges, particularly a five-year decline compared to broader market gains.
TCM Ltd Faces Selling Pressure with 5% Daily Decline and 12.52% Loss Over Three Days
TCM Ltd is experiencing notable selling pressure, with a three-day decline totaling 12.52%. Despite a strong monthly performance, recent trends suggest a shift in market sentiment. Over the past three years, TCM Ltd has significantly underperformed the Sensex, raising concerns among investors regarding its future outlook.
Why is TCM falling/rising?
As of 07-Nov, TCM Ltd's stock price is Rs 60.40, down 3.08% after consecutive declines, though it has positive returns over the past week and month. The decrease in delivery volume suggests reduced investor participation, and while TCM has outperformed the Sensex year-to-date, the recent price drop may indicate profit-taking or market corrections.
TCM Ltd Faces Selling Pressure with 4.99% Decline, Marking Trend Reversal After Gains
TCM Ltd is experiencing significant selling pressure, with its stock price declining after a period of gains. Despite a strong performance over the past week and month, longer-term metrics indicate challenges. The recent downturn may be linked to profit-taking and broader market dynamics affecting microcap stocks in the commodity chemicals sector.
TCM Hits New 52-Week High of Rs. 67.4, Showcasing Strong Momentum
TCM, a microcap in the commodity chemicals sector, achieved a new 52-week high of Rs. 67.4 on November 4, 2025, following a 43.94% gain over six days. The company has outperformed its sector and delivered a 22.20% return over the past year, showcasing strong market resilience.
Why is TCM falling/rising?
As of 03-Nov, TCM Ltd's stock price is at 65.04, having increased by 13.05% and reached a 52-week high of Rs. 66.9. The stock has outperformed the market significantly, gaining 43.04% over the past week, with strong investor interest reflected in a 214.33% rise in delivery volume.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}

